Development of a solid phase extraction for 13 ‘new’ generation antidepressants and their active metabolites for gas chromatographic–mass spectrometric analysis
- 9 December 2005
- journal article
- Published by Elsevier BV in Journal of Chromatography A
- Vol. 1098 (1-2), 19-29
- https://doi.org/10.1016/j.chroma.2005.08.059
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- A rapid HPLC-DAD method for the analysis of fluoxetine and norfluoxetine in plasma from overdose patientsJournal of Pharmaceutical and Biomedical Analysis, 2004
- N-Substituted Piperazines Abused by Humans Mimic the Molecular Mechanism of 3,4-Methylenedioxymethamphetamine (MDMA, or ‘Ecstasy’)Neuropsychopharmacology, 2004
- Screening for and validated quantification of amphetamines and of amphetamine‐ and piperazine‐derived designer drugs in human blood plasma by gas chromatography/mass spectrometryJournal of Mass Spectrometry, 2003
- Paroxetine Associated Hepatotoxicity: A Report of 3 Cases and a Review of the LiteraturePharmacopsychiatry, 2002
- Treating Depression With Selective Serotonin Reuptake Inhibitors: A Practical ApproachMayo Clinic Proceedings, 2001
- Alpha-1-acid glycoproteinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
- Therapeutic Drug Monitoring of AntidepressantsClinical Pharmacokinetics, 1999
- Interaction Between Antidepressants and Alpha1-Adrenergic Receptor Antagonists on the Binding to Alpha1-Acid GlycoproteinJournal of Pharmaceutical Sciences, 1986
- The Relative Importance of Albumin, Lipoproteins and Orosomucoid for Drug Serum BindingClinical Pharmacokinetics, 1984
- Disease-induced Changes in the Plasma Binding of Basic DrugsClinical Pharmacokinetics, 1980